The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation
Abstract
In vivo injection of the hamster anti‐murine CD3 monoclonal antibody 145 2C11 into BALB/c mice induces a massive systemic release of several cytokines. Very high circulating levels of tumor necrosis factor are detected both by enzyme‐linked immunosorbent assay and L‐929 bioassay 90 min following a single injection of 10 μg/mouse 145 2C11. Peak circulating levels of exclusively T cell‐derived products such as interferon‐γ, interleukin 2 and interleukin 3 are also detected 90 min to 8 h post‐injection. Importantly, this cytokine release is transient since none of these cytokines are still present 12 to 24 h post‐injection. In parallel to cytokine release, 145 2C11‐treated mice (10 μg/mouse) exhibit somnolence, hypomotility (quantified by actimetry), hypothermia, diarrhea and piloerection. At this dosage, the physical reaction is not lethal and reverses in all mice by 48 h post‐injection. Severe but again reversible anatomopathological changes are also observed: massive cellular depletion, necrosis and edema of lymphoid organs, leakage syndrome and inflammatory cell infiltrates of the lung, cell vacuolization, necrosis and vascular congestion of the liver. All these data are similar to the clinical and immunological manifestations of the OKT3‐induced reaction in patients and, thus, provide an invaluable experimental tool to study its mechanisms and explore its prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Avis, F. P., Leitman, S., Linehan, W. M., Robertson, C. N., Lee, R. E., Rubin, J. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161501 · Cited by 2,735
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1374 · Cited by 1,593
Self-citationDialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 884
Philip, R., & Epstein, L. B. (1986) · Nature · doi:10.1038/323086a0 · Cited by 767
Ortho Multicenter Transplant Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130601 · Cited by 708
Production of High-Titered Interferon in Cultures of Human Diploid Cells
Havell, E. A., & Vilček, J. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.6.476 · Cited by 470
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
Wofsy, D., & Seaman, W. E. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.2.378 · Cited by 458
TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODY
Cosimi, A. B., BURTON, R. C., COLVIN, R. B., GOLDSTEIN, G., DELMONICO, F. L., LAQUAGLIA, M. P., TOLKOFF-RUBIN, N., RUBIN, R. H., HERRIN, J. T., & RUSSELL, P. S. (1981) · Transplantation · doi:10.1097/00007890-198112000-00018 · Cited by 389
Purification and physico-chemical characterization of rabbit tumor necrosis factor.
Ruff, M. R., & Gifford, G. E. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1671 · Cited by 385
Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.
Arya, S. K., Wong-Staal, F., & Gallo, R. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.1.273 · Cited by 383
Sheehan, K. C. F., Ruddle, N. H., & Schreiber, R. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3884 · Cited by 379
Self-citationBroudy, V. C., Kaushansky, K., Segal, G. M., Harlan, J. M., & Adamson, J. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7467 · Cited by 373
Cuturi, M. C., Murphy, M., Costa-Giomi, M. P., Weinmann, R., Perussia, B., & Trinchieri, G. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.6.1581 · Cited by 360
ABRAMOWICZ, D., SCHANDENE, L., GOLDMAN, M., CRUSIAUX, A., VEREERSTRAETEN, P., PAUW, L. D., WYBRAN, J., KINNAERT, P., DUPONT, E., & TOUSSAINT, C. (1989) · Transplantation · doi:10.1097/00007890-198904000-00008 · Cited by 352
Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
Ruggiero, V, Tavernier, J., Fiers, W., & Baglioni, C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2445 · Cited by 318
Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
Tsujimoto, M., Yip, Y. K., & Vilček, J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2441 · Cited by 301
(1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202117 · Cited by 269
Acute in vivo effects of human recombinant tumor necrosis factor.
Remick, D. G., Kunkel, R. G., Larrick, J. W., & Kunkel, S. L. (1987) · PubMed · Cited by 256
Waage, A., & Bakke, O. (1988) · PubMed · Cited by 248
Beutler, B., Tkacenko, V, Milsark, I., Krochin, N., & Cerami, A. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.5.1791 · Cited by 235
THE MEASUREMENT OF THE INFLUENCE OF DRUGS ON VOLUNTARY ACTIVITY IN MICE
DEWS, P. B. (1953) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1953.tb00749.x · Cited by 218
Human in vivo antigenic modulation induced by the anti‐T cell OKT3 monoclonal antibody
Chatenoud, L., Baudrihaye, M. F., Kreis, H., Goldstein, G., Schindler, J., & Bach, J. (1982) · European Journal of Immunology · doi:10.1002/eji.1830121116 · Cited by 201
Self-citationSung, S. S., Bjorndahl, J. M., Wang, C. Y., Kao, H. T., & Fu, S. M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.937 · Cited by 185
Hirsch, R., Eckhaus, M., Auchincloss, H., Sachs, D. H., & Bluestone, J. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.11.3766 · Cited by 167
Self-citationLachman, L. B., Brown, D. C., & Dinarello, C. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.9.2913 · Cited by 164
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
Benjamin, R. J., Cobbold, S. P., Clark, M. R., & Waldmann, H. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1539 · Cited by 162
Talmadge, J. E., Tribble, H. R., Pennington, R., Phillips, H., & Wiltrout, R. H. (1987) · PubMed · Cited by 134
Cannon, J. G., van der Meer, J. W., Kwiatkowski, D. P., Endres, S., Lonnemann, G., Burke, J. F., & Dinarello, C. A. (1988) · PubMed · Cited by 122
ONE-MONTH PROPHYLACTIC USE OF OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTS
Debure, A., Chkoff, N., Chatenoud, L., Lacombe, M., Campos, H. D. H., Noël, L., Goldstein, G., Bach, J., & Kreis, H. (1988) · Transplantation · doi:10.1097/00007890-198803000-00009 · Cited by 104
Self-citationMacDonald, H. R., Thiernesse, N., & Cerottini, J. C. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.5.1671 · Cited by 93
Talmadge, J. E., Bowersox, O., Tribble, H. R., Lee, S. H., Shepard, H. M., & Liggitt, D. (1987) · PubMed Central · Cited by 91
Clinical use of OKT3: The role of cytokine release and xenosensitization
Chatenoud, L., Ferran, C. J., Legendre, C. M., et al. (1988) · Journal of Autoimmunity · doi:10.1016/0896-8411(88)90054-6 · Cited by 27
Self-citation
Cited by
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Self-citationEpithelial Barriers in Homeostasis and Disease
Marchiando, A. M., Graham, W. V., & Turner, J. R. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092135 · Cited by 613
Belghith, M., Bluestone, J. A., Barriot, S., Mégret, J., Bach, J.-F., & Chatenoud, L. (2003) · Nature Medicine · doi:10.1038/nm924 · Cited by 586
Self-citationMizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1529 · Cited by 517
Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion
Taupin, V., Toulmond, S., Serrano, A., Benavides, J., & Zavala, F. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90008-m · Cited by 512
Metadata
- Authors
- Ferran, C., Sheehan, K., Dy, M., Schreiber, R., Merite, S., Landais, P., Noel, L., Grau, G., Bluestone, J., Bach, J., & Chatenoud, L.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1990-03
- Volume
- 20
- Issue
- 3
- Pages
- 509-515
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2074011660
- Cited by
- 264
- References
- 35
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.